Skip to main content
Top
Published in: Lasers in Medical Science 3/2008

01-07-2008 | Original Article

Uptake and retention of the photosensitizer mono-l-asparthyl chlorine e6 in experimental malignant glioma

Authors: Hiroyuki Matsumura, Jiro Akimoto, Jo Haraoka, Katsuo Aizawa

Published in: Lasers in Medical Science | Issue 3/2008

Login to get access

Abstract

The objective of the study was to investigate the potential of mono-l-aspartyl chlorine e6 (NPe6), a water-soluble photosensitizer derived from chlorophyll, for use in photodynamic diagnosis (PDD) of malignant brain tumor. A C6 glioma cell line was transplanted in the SD rat brain to create a brain tumor model. Five days after transplantation, NPe6 was administrated via the tail vein at concentrations ranging from 1.25 to 10 mg/kg; then the skull was opened in the rat brain, the site of tumor transplant was irradiated with a diode laser beam at 664 nm, and the time-course intensity and distribution of emerging fluorescence were observed. Furthermore, the correlation between fluorescence distribution and histopathological findings was investigated in the removed brain. Fluorescence was observed in the site of brain tumor transplant from 5 min after injection, and stable fluorescence was recognized at the site until 4 h after administration. No differences were noted in fluorescence intensity at NPe6 doses of 2.5 mg/kg or more; therefore, it was possible to estimate the optimal dose range. Fluorescence distribution had a clear correlation with tumor cell density, and it was possible to capture the margin of tumor cell invasion with fluorescence. The photosensitizer NPe6 is capable of assessing tumor cell density in malignant glioma tissue in terms of differences in fluorescence intensity. The usefulness of PDD using 5-aminoleveulinic acid during surgery for malignant glioma has been recognized in recent years. The results of the present study suggested the potential of NPe6 as a promising photosensitizer for use in PDD for accurate grasp of the extent of removal during the course of malignant glioma surgery.
Literature
1.
go back to reference Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198PubMed Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198PubMed
2.
go back to reference Sawaya R, Hammound M, Schoppa D, Hess KR, Wu SZ, Shi WM, Wildrick DM (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044–1056PubMedCrossRef Sawaya R, Hammound M, Schoppa D, Hess KR, Wu SZ, Shi WM, Wildrick DM (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044–1056PubMedCrossRef
3.
go back to reference Moore GE, Peyton WT, French LA (1948) The clinical use of fluorescein on neurosurgery. The localization of brain tumors. J Neurosurg 5:392–398PubMed Moore GE, Peyton WT, French LA (1948) The clinical use of fluorescein on neurosurgery. The localization of brain tumors. J Neurosurg 5:392–398PubMed
4.
go back to reference Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ (2000) Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93:1003–1013PubMedCrossRef Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ (2000) Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93:1003–1013PubMedCrossRef
5.
go back to reference Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, ReulenHJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol 7:392–401PubMedCrossRef Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, ReulenHJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol 7:392–401PubMedCrossRef
6.
go back to reference Bellnier DA, Ho YK, Pandey RK, Missert JR, Dougherty TJ (1989) Distribution and elimination of Photofrin II in mice. Photochem Photobiol 50(2):221–228PubMedCrossRef Bellnier DA, Ho YK, Pandey RK, Missert JR, Dougherty TJ (1989) Distribution and elimination of Photofrin II in mice. Photochem Photobiol 50(2):221–228PubMedCrossRef
7.
go back to reference Kaye AH, Morstyn G, Ashcroft RG (1985) Uptake and retention of hematoporphyrin derivative in an in vivo/in vitro model of cerebral glioma. Neurosurgery 17:883–890PubMedCrossRef Kaye AH, Morstyn G, Ashcroft RG (1985) Uptake and retention of hematoporphyrin derivative in an in vivo/in vitro model of cerebral glioma. Neurosurgery 17:883–890PubMedCrossRef
8.
go back to reference Kaye AH, Morstyn G, Apuzzo ML (1988) Photoradiation therapy and its potential in the management of neurological tumors. J Neurosurg 69:1–14PubMed Kaye AH, Morstyn G, Apuzzo ML (1988) Photoradiation therapy and its potential in the management of neurological tumors. J Neurosurg 69:1–14PubMed
9.
go back to reference Muller PJ, Wilson BC (1996) Photodynamic therapy for malignant newly diagnosed supratentorial gliomas. J Clin Laser Med Surg 4:263–270 Muller PJ, Wilson BC (1996) Photodynamic therapy for malignant newly diagnosed supratentorial gliomas. J Clin Laser Med Surg 4:263–270
10.
go back to reference Perria C, Capuzzo T, Cavagnaro C, Datti R, Francaviglia N, Rivano C, Tercero VE (1980) First attempts at the photodynamic treatment of human gliomas. J Neurosurg Sci 24:119–129PubMed Perria C, Capuzzo T, Cavagnaro C, Datti R, Francaviglia N, Rivano C, Tercero VE (1980) First attempts at the photodynamic treatment of human gliomas. J Neurosurg Sci 24:119–129PubMed
11.
go back to reference Perria C, Carai M, Falzoi A, Orunesu G, Rocca A, Massareli G, Francaviglia N, Joli G (1998) Photodynamic therapy of malignant brain tumors: clinical results of, difficulties with, questions about, and future prospects for the neurosurgical applications. Neurosurgery 23:557–563CrossRef Perria C, Carai M, Falzoi A, Orunesu G, Rocca A, Massareli G, Francaviglia N, Joli G (1998) Photodynamic therapy of malignant brain tumors: clinical results of, difficulties with, questions about, and future prospects for the neurosurgical applications. Neurosurgery 23:557–563CrossRef
12.
go back to reference Popovic EA, Kaye AH, Hill JS (1995) Photodynamic therapy of brain tumors. Sem Surg Oncol 11:335–345CrossRef Popovic EA, Kaye AH, Hill JS (1995) Photodynamic therapy of brain tumors. Sem Surg Oncol 11:335–345CrossRef
13.
go back to reference Hill JS, Kaye AH, Sawyer WH, Morstyn G, Megison PD, Stylli SS, Koo MS, Gonzales MF, Vardaxis NJ, Johnson CI (1990) Selective uptake of hematoporphyrin derivative into human cerebral glioma. Neurosurgery 26:248–254PubMedCrossRef Hill JS, Kaye AH, Sawyer WH, Morstyn G, Megison PD, Stylli SS, Koo MS, Gonzales MF, Vardaxis NJ, Johnson CI (1990) Selective uptake of hematoporphyrin derivative into human cerebral glioma. Neurosurgery 26:248–254PubMedCrossRef
14.
go back to reference Hill JS, Kahl SB, Kaye AH, Stylli SS, Koo MS, Gonzales MF, Vardaxis NJ, Johnson CI (1992) Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma. Proc Natl Acad Sci U S A 89:1785–1789PubMedCrossRef Hill JS, Kahl SB, Kaye AH, Stylli SS, Koo MS, Gonzales MF, Vardaxis NJ, Johnson CI (1992) Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma. Proc Natl Acad Sci U S A 89:1785–1789PubMedCrossRef
15.
go back to reference Aizawa K, Okunaka C, Ohtani T, Kawabe H, Yasunaka Y, O’Hata S, Ohtomo N, Nishiyama K, Konaka C, Kato H, Hayata Y, Saito T (1987) Localization of mono-l-aspartyl chlorine e6 (NPe6) in mouse tissue. Photochem Photobiol 46(5):789–793PubMedCrossRef Aizawa K, Okunaka C, Ohtani T, Kawabe H, Yasunaka Y, O’Hata S, Ohtomo N, Nishiyama K, Konaka C, Kato H, Hayata Y, Saito T (1987) Localization of mono-l-aspartyl chlorine e6 (NPe6) in mouse tissue. Photochem Photobiol 46(5):789–793PubMedCrossRef
16.
go back to reference Kessel D (1997) Pharmacokinetics of N-aspartyl chlorine e6 in cancer patients. J Photochem Photobiol B 39:81–83PubMedCrossRef Kessel D (1997) Pharmacokinetics of N-aspartyl chlorine e6 in cancer patients. J Photochem Photobiol B 39:81–83PubMedCrossRef
17.
go back to reference Roberts WG, Berns MW (1989) In vitro Photosensitization I. Cellular uptake and subcellular localization of Mono-l-asparthyl Chlorin e6, Chloro-aluminuim sulfonated phthalocyanine, and Photofrin II. Lasers Surg Med 9:90–101PubMedCrossRef Roberts WG, Berns MW (1989) In vitro Photosensitization I. Cellular uptake and subcellular localization of Mono-l-asparthyl Chlorin e6, Chloro-aluminuim sulfonated phthalocyanine, and Photofrin II. Lasers Surg Med 9:90–101PubMedCrossRef
18.
go back to reference Kessel D, Whitcomb KL, Schulz V (1992) Lipoprotein-mediated distribution of N-aspartyl chlorine-E6 in the mouse. Photochem Photobiol 56:51–56PubMedCrossRef Kessel D, Whitcomb KL, Schulz V (1992) Lipoprotein-mediated distribution of N-aspartyl chlorine-E6 in the mouse. Photochem Photobiol 56:51–56PubMedCrossRef
19.
go back to reference Kessel D (1995) Interactions between N-aspartyl chlorine e6, detergent micelles and plasma lipoproteins. Photochem Photobiol 61:646–649PubMed Kessel D (1995) Interactions between N-aspartyl chlorine e6, detergent micelles and plasma lipoproteins. Photochem Photobiol 61:646–649PubMed
20.
go back to reference Tsuchida T, Aizawa K, Konaka C, Kato H (1993) Interaction of bovin serum albumin with mono-l-aspartyl chlorine e6 by spectrophotometry. Lasers Life Sci 5:155–164 Tsuchida T, Aizawa K, Konaka C, Kato H (1993) Interaction of bovin serum albumin with mono-l-aspartyl chlorine e6 by spectrophotometry. Lasers Life Sci 5:155–164
21.
go back to reference Sheyhedin I, Okunaka T, Kato H, Yamamoto Y, Sakaniwa N, Konaka C, Aizawa K (2000) Localization of experimental submucosal esophageal tumor in rabbits by using mono-l-aspartyl chlorine e6 and long-wavelength photodynamic excitation. Lasers Surg Med 26:83–89PubMedCrossRef Sheyhedin I, Okunaka T, Kato H, Yamamoto Y, Sakaniwa N, Konaka C, Aizawa K (2000) Localization of experimental submucosal esophageal tumor in rabbits by using mono-l-aspartyl chlorine e6 and long-wavelength photodynamic excitation. Lasers Surg Med 26:83–89PubMedCrossRef
22.
go back to reference Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle DG, Miffelman A (1978) Photoradiation therapy. a new method for the treatment of malignant tumors. Cancer Res 38:2628–2635PubMed Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle DG, Miffelman A (1978) Photoradiation therapy. a new method for the treatment of malignant tumors. Cancer Res 38:2628–2635PubMed
23.
go back to reference Dougherty TJ (1987) Photosensitizers. Therapy and detection of malignant tumors. Photochem Photobiol 45:879–889PubMedCrossRef Dougherty TJ (1987) Photosensitizers. Therapy and detection of malignant tumors. Photochem Photobiol 45:879–889PubMedCrossRef
24.
go back to reference Kennedy JC, Pottier RH (1991) Endogeneous protoporphyrin IX, a clinically useful Photosinsitizer for photodynamic therapy. J Photochem Photobiol B 30:14(4)275–292 Kennedy JC, Pottier RH (1991) Endogeneous protoporphyrin IX, a clinically useful Photosinsitizer for photodynamic therapy. J Photochem Photobiol B 30:14(4)275–292
25.
go back to reference Ferrario A, Kessel D, Gomer CJ (1992) Metabolic properties and photosensitizing responsiveness of mono-l-aspartyl chlorine e6 in a mouse tumor model. Cancer Res 52:2890–2893PubMed Ferrario A, Kessel D, Gomer CJ (1992) Metabolic properties and photosensitizing responsiveness of mono-l-aspartyl chlorine e6 in a mouse tumor model. Cancer Res 52:2890–2893PubMed
26.
go back to reference Gomer CJ, Ferrario A (1990) Tissue distribution and photosensitizing properties of mono-l-aspartyl chlorine e6 in a mouse tumor model. Cancer Res 50:3985–3990PubMed Gomer CJ, Ferrario A (1990) Tissue distribution and photosensitizing properties of mono-l-aspartyl chlorine e6 in a mouse tumor model. Cancer Res 50:3985–3990PubMed
27.
go back to reference Louis-Michel WKS, Wang KK, Zinsmeister AR (1998) Mono-l-aspartyl chlorine e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model. Cancer 82:421–427CrossRef Louis-Michel WKS, Wang KK, Zinsmeister AR (1998) Mono-l-aspartyl chlorine e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model. Cancer 82:421–427CrossRef
28.
go back to reference Nakamura J, Sugiyama Y, Kajiwara H, Nakamura M, Watanabe M, Tanaka H, Terada T, Nagao J, Kusachi S, Saida Y, Usui S, Aizawa K (2000) [Photodynamic diagnosis and photodynamic therapy for experimental hepatoma with ME 2906]. Gan To Kagaku Ryoho 27:1876–1878PubMed Nakamura J, Sugiyama Y, Kajiwara H, Nakamura M, Watanabe M, Tanaka H, Terada T, Nagao J, Kusachi S, Saida Y, Usui S, Aizawa K (2000) [Photodynamic diagnosis and photodynamic therapy for experimental hepatoma with ME 2906]. Gan To Kagaku Ryoho 27:1876–1878PubMed
29.
go back to reference Knobler F, Poh-Fitzpatrick MB, Kravetz D, Vincent WR, Muller-Eberhand U, Vincent SH (1989) Interaction of hemopexin, albumin and liver fatty acid binding protein with protoporphyrin. Hepatology 10(6):995–997PubMedCrossRef Knobler F, Poh-Fitzpatrick MB, Kravetz D, Vincent WR, Muller-Eberhand U, Vincent SH (1989) Interaction of hemopexin, albumin and liver fatty acid binding protein with protoporphyrin. Hepatology 10(6):995–997PubMedCrossRef
30.
go back to reference Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK (1994) Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res 54:4564–4568PubMed Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK (1994) Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res 54:4564–4568PubMed
31.
go back to reference Roberts WG, Liaw LHL, Berns MW (1989) In vitro photosensitization II. An electron microscopy study of cellular destruction with mono-l-aspartyl chlorine e6 and photofrin II. Lasers Surg Med 9:102–108PubMedCrossRef Roberts WG, Liaw LHL, Berns MW (1989) In vitro photosensitization II. An electron microscopy study of cellular destruction with mono-l-aspartyl chlorine e6 and photofrin II. Lasers Surg Med 9:102–108PubMedCrossRef
32.
go back to reference Roberts WG, Shiau FY, Nelson JS, Smith KM, Berns MW (1988) In vitro characterization of monoaspartyl chlorine e6 for photodynamic therapy. J Natl Cancer Inst 80:330–336PubMedCrossRef Roberts WG, Shiau FY, Nelson JS, Smith KM, Berns MW (1988) In vitro characterization of monoaspartyl chlorine e6 for photodynamic therapy. J Natl Cancer Inst 80:330–336PubMedCrossRef
33.
go back to reference Nelson JS, Liaw LH, Orenstein A, Roberts WG, Berns ME (1988) Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorine, and phthalocyanine. J Natl Cancer Inst 80:1599–1605PubMedCrossRef Nelson JS, Liaw LH, Orenstein A, Roberts WG, Berns ME (1988) Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorine, and phthalocyanine. J Natl Cancer Inst 80:1599–1605PubMedCrossRef
34.
go back to reference Nelson JS, Roberts WG, Berns MW (1987) In vivo studies on the utilization of mono-l-aspartyl chlorine (NPe6) for photodynamic therapy. Cancer Res 47:4681–4685PubMed Nelson JS, Roberts WG, Berns MW (1987) In vivo studies on the utilization of mono-l-aspartyl chlorine (NPe6) for photodynamic therapy. Cancer Res 47:4681–4685PubMed
35.
go back to reference Katsumi T, Aizawa K, Kuroiwa Y, Saito K, Kurata Y, Ii Y, Okunaka T, Konaka C, Kato H (1996) Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-l-aspartyl chlorine e6. Photochem Photobiol 64:671–675PubMedCrossRef Katsumi T, Aizawa K, Kuroiwa Y, Saito K, Kurata Y, Ii Y, Okunaka T, Konaka C, Kato H (1996) Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-l-aspartyl chlorine e6. Photochem Photobiol 64:671–675PubMedCrossRef
Metadata
Title
Uptake and retention of the photosensitizer mono-l-asparthyl chlorine e6 in experimental malignant glioma
Authors
Hiroyuki Matsumura
Jiro Akimoto
Jo Haraoka
Katsuo Aizawa
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Lasers in Medical Science / Issue 3/2008
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-007-0469-3

Other articles of this Issue 3/2008

Lasers in Medical Science 3/2008 Go to the issue